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Abstract
Background
Randomized controlled trials evaluate the effectiveness of interventions for central venous
access devices, however, high complication rates remain. Scoping reviews map the avail-
able evidence and demonstrate evidence deficiencies to focus ongoing research priorities.
Method
A scoping review (January 2006–December 2015) of randomized controlled trials evalu-
ating the effectiveness of interventions to improve central venous access device out-
comes; including peripherally inserted central catheters, non-tunneled, tunneled and
totally implanted venous access catheters. MeSH terms were used to undertake a sys-
tematic search with data extracted by two independent researchers, using a standardized
data extraction form.
Results
In total, 178 trials were included (78 non-tunneled [44%]; 40 peripherally inserted central
catheters [22%]; 20 totally implanted [11%]; 12 tunneled [6%]; 6 non-specified [3%]; and 22
combined device trials [12%]). There were 119 trials (68%) involving adult participants only,
with 18 (9%) pediatric and 20 (11%) neonatal trials. Insertion-related themes existed in 38%
of trials (67 RCTs), 35 RCTs (20%) related to post-insertion patency, with fewer trials on
infection prevention (15 RCTs, 8%), education (14RCTs, 8%), and dressing and secure-
ment (12 RCTs, 7%). There were 46 different study outcomes reported, with the most com-
mon being infection outcomes (161 outcomes; 37%), with divergent definitions used for
catheter-related bloodstream and other infections.
Conclusion
More high quality randomized trials across central venous access device management are
necessary, especially in dressing and securement and patency. These can be encouraged
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by having more studies with multidisciplinary team involvement and consumer engagement.
Additionally, there were extensive gaps within population sub-groups, particularly in tun-
neled devices, and in pediatrics and neonates. Finally, outcome definitions need to be uni-
fied for results to be meaningful and comparable across studies.
Introduction
Central venous access devices (CVADs) provide access to the greater vascular system to
administer therapy contraindicated to be given peripherally, for longer term treatment, and
for venous monitoring and blood sampling [1]. Patients requiring CVADs are heterogeneous,
with varying ages, acute and chronic illnesses, across hospitals and in community care. There
are many different CVAD types inserted for different treatment requirements; for example,
long or short term duration, and continuous or intermittent therapy. CVAD care is complex
and multi-faceted; clinicians from diverse clinical specialties are involved in their insertion
and management [1–4].
Despite the prevalence of CVADs in acute and chronic care, serious insertion and manage-
ment complications associated with CVADs continue to be prevalent [5–10]. Many complica-
tions, including bloodstream infection, are considered a preventable source of patient harm
and have a significant negative impact on patients and healthcare costs [11]. Developing, test-
ing and implementing effective interventions to prevent CVAD-associated harm are important
considerations for healthcare researchers, clinicians, and patients. In order to improve the
quality and safety of CVADs, many randomized controlled trials (RCTs) have been conducted
to evaluate the effectiveness of healthcare interventions.
The RCT is considered to be the “gold standard” for evaluating the effectiveness of an inter-
vention, as it provides reliable evidence with minimal risk of bias compared to other study
designs [12]. Clinicians refer to results of RCTs and systematic reviews to guide clinical deci-
sion-making, however, this may be challenged if results cannot be generalized to their popula-
tion because of too few RCTs, small sample sizes, poor reporting, and a lack of clear effect [13].
Therefore, it is important for researchers to develop their research agenda based upon the
identified priority areas and clinical needs, while minimizing unnecessary duplication of
research and associated costs.
Scoping reviews are used to map the existing research in a given field and to highlight the
gaps in evidence [14–17]. They examine the breadth of literature published, with the aim of
providing insights and guidance for clinicians and researchers on where to focus their research
[17]. The aim of this scoping review was to reveal the RCTs conducted in relation to CVADs
in the past decade and to synthesize the patient populations and clinical settings studied, inter-
ventional themes addressed, and the outcome measures used.
Methods
Review framework
This scoping review was conducted using the framework outlined by Arksey and O’Malley [14]
and modified by the Cochrane Public Health Group [14, 16], which is used extensively [18–20].
The framework consists of the following steps: 1. Identify the research question; 2. Identify rele-
vant studies; 3. Select studies for inclusion; 4. Sort, collate, and analyze data; and 5. Summarize
and report results [14]. Consensus on methodology and inclusion/exclusion criteria were estab-
lished during the first phase of the project to ensure consistency in decision making.
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Identify the research questions
The objectives of the review were to answer the following questions:
1. What RCTs have been conducted on the effectiveness of interventions to improve CVAD
outcomes within contemporary literature (< 10 years), and what were the study
characteristics?
2. What CVAD types, population demographics, and clinical settings were included?
3. What were the interventional themes studied?
4. What outcome measures were reported?
Identify relevant studies
A systematic search was undertaken. Studies were eligible for inclusion if they met predefined
inclusion criteria: (1) employed an RCT design; (2) evaluated interventions to improve out-
comes associated with CVADs; and (3) were published between 1 January 2006 and 31 Decem-
ber 2015. CVADs were limited to peripherally inserted central catheter (PICC), non-tunneled
CVAD (NTCVAD), tunneled CVAD, and totally implantable venous access device (TIVAD)
used in any patient population. Umbilical catheters and dialysis catheters were excluded from
the review as they are used in special population groups only. Studies comprising more than
one CVAD type were included in the scoping review if the article specified the results for
each device type, allowing the results of the target devices to be extracted. All participant
ages and settings (inpatient and ambulatory) were included. We excluded non-RCT designs
(including cross-over design), secondary analysis of RCTs, non-English studies without an
English abstract, and non-human studies.
Search strategy
The search strategy was developed with the assistance of a university health sciences librarian.
Databases were systematically and independently searched on the 19th February, 2016. Data-
bases included PubMed (US National Library of Medicine), Cochrane Central Register of
Controlled Trials (the Cochrane Library), Cumulative Index to Nursing and Allied Health Lit-
erature (CINAHL), and Medline (US National Library of Medicine). (See S1 File for search
terms). Reference lists of retrieved systematic reviews were reviewed to ensure all potential
RCTs were included.
Study selection and data extraction
References were imported into EndNote™ (Clarivate Analytics) and then sorted and examined
throughout the inclusion/exclusion process [14]. Each reference, title and abstract was initially
dual-screened by a pair of two independent investigators (MT, GB, AU, SK). Two independent
reviewers then reviewed the full text of selected studies for inclusion/exclusion criteria, and, if
eligible, extracted the data using a standardized data extraction form. If the group was unclear
of the inclusion, all four reviewers met until an agreement was reached.
Data sorting, collating, and analysis
Data were extracted into a Microsoft Excel file to organize the data under the following head-
ings: first author; year of publication; country; first author profession; title of journal; method
of randomization; study population (inpatient/ambulant; neonates/pediatrics/adults; clinical
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specialities); sample size; discipline of CVAD inserter; interventional theme; outcome mea-
sures; key findings; and grant funding. The risk of bias of the individual studies was not for-
mally assessed in the same way as a systematic review [21]. This is because of the differing
goals of scoping reviews, which are designed to illuminate the breadth rather than the depth of
available research [14, 15]. However, this review incorporates the appraisal of the methodolog-
ical quality by including assessment of randomization methods and outcome definitions [22].
Authors were not contacted for further information or to obtain full-text.
Summarizing and reporting results
Preliminary tables were constructed to identify topics that had been the focus of many RCTs
and topics that were lacking in evidence. Microsoft Excel was used to create graphs and tables.
Fig 1 describes the flow of inclusion and exclusion for the study selection, in accordance with
the referred Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines [23]. Database searching identified 2,695 RCTs and an additional 28 RCTs were
added after reviewing the reference lists of 77 identified systematic reviews. After duplicates
and studies with non-relevant abstracts were removed, 222 RCTs were reviewed. Twenty-nine
RCTs provided abstract information only.
Results
Characteristics of included RCTs
The final review included 178 RCTs (78 non-tunneled [24–101]; 40 PICC [102–141]; 20 totally
implanted [142–161]; 12 tunneled [162–173]; 6 non-specified [174–179]; 22 combined [180–
201]; See S1 Table for included studies). The non-specified category was created to classify
studies that did not specify the type of CVAD. There were nine pilot studies (6%) and 28
multi-center studies (16%). The largest number of RCTs were published in the USA (32 RCTs;
18%), followed by Italy (12 RCTs; 7%), and Brazil, Netherlands, France, and Germany (10
RCTs each; 6%).
First authors were mainly medical doctors (96 RCTs; 54%), followed by departmental infor-
mation only (48 RCTs; 27%), and nurses (13 RCTs; 7%). Information regarding grant monies
was listed as public/departmental source (43 RCTs; 24%), followed by missing/not stated
(27 RCTs; 15%), or missing/abstract information only (25 RCTs; 14%). Industry grants
accounted for 19 RCTs (11%), and 13 RCTs received both public and private funding (7%).
Forty percent (n = 70) of RCTs used computer-generated allocation, which is the standard
method of randomization [202]. However, 42 RCTs (24%) did not state the randomization
method (excluding those that provided abstract information only), and some studies had ques-
tionable randomization methods, such as alternate allocation, random admission to ward allo-
cation, and lottery method, which can potentially be vulnerable to subversion [202].
Population demographics and clinical settings of included RCTs
Patient populations studied were mostly adults (119 RCTs: 68%) (See Table 1). In younger
patients, neonates were the target population in 20 RCTs (11%) and pediatrics in 18 RCTs
(10%). There was a difference in frequency of use of CVAD types in different populations.
Non-tunneled CVADs were the most popular catheter type studied in adults (n = 23,435, 60%
of all adult RCTs), compared to 24% of all pediatric RCTs (n = 431) and 4% of all neonate
RCTs (n = 87). Most studied CVAD types for pediatrics and neonates were tunneled CVADs
(n = 744, 41% of all pediatric RCTs) and PICCs respectively (n = 1572, 78% of neonate RCTs).
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Pediatrics comprised 4% (n = 1816) of the total sample size compared to adults (n = 38,979,
84%) and neonates (n = 2009, 4%).
The most prevalent clinical specialties for CVAD RCTs were intensive care units (ICU) (61
RCTs; 34%), with a further 4 RCTs including some ICU patients, followed by hematology/
oncology settings (49 RCTs; 27%). Most non-tunneled CVAD studies (78 RCTs) took place in
Fig 1. Flowchart of articles screened for inclusion in the scoping review. RCT: Randomized Controlled Trial; CVAD:
Central Venous Access Device; PICC: Peripherally Inserted Central Catheter; TIVAD: Totally Implantable Vascular Access
Device.
https://doi.org/10.1371/journal.pone.0174164.g001
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ICUs (37 RCTs; 47%) or operating rooms (18 RCTs, 23%). PICCs were studied predominantly
in ICUs (19 RCTs), of which the majority were neonatal ICU (16 RCTs; 84%). Hematology/
oncology was the most prevalent clinical setting for TIVAD (16 out of 20 RCTs; 80%), tun-
neled CVAD (10 out of 12 RCTs; 83%), and combined catheter (11 out of 22 RCTs, 50%)
studies. No studies were conducted solely in the emergency department (ED), but two RCTs
included some ED devices. Staff education was the focus of 13 RCTs (7%); these were primarily
simulation studies and only two detailed nursing education. The majority of CVADs were
inserted by doctors or medical interns (75 RCTs; 42%). Vascular access nurses or vascular
Table 1. Population table of included RCTs (N = 178 studies, 46,258 participants).
NTCVAD PICC TIVAD Tunneled Combined CVAD-NS Total
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Population (number of participants)
Adult 23,435
(60%)
2,742 (7%) 4,322
(11%)
917 (2%) 7,222
(19%)
341 (1%) 38,979
(100%)
Pediatrics 431 (24%) 240 (13%) 151 (8%) 744 (41%) 250 (14%) 0 1,816 (100%)
Neonates 87 (4%) 1,572
(78%)
0 0 350 (18%) 0 2,009 (100%)
Combined 240 (18%) 0 0 0 1089 (82%) 0 1,329 (100%)
Staff 724 (88%) 32 (4%) 0 0 0 65 (8%) 821 (100%)
Unknown 394 (30%) 250 (19%) 0 0 0 660 (51%) 1,304 (100%)
Total 25,311
(55%)
4,836
(10%)
4,473
(10%)
1,661
(4%)
8,911
(19%)
1,066
(2%)
46,258
(100%)
Setting (number of studies)
Inpatient 65 (47%) 27 (19%) 11 (8%) 12 (9%) 20 (14%) 3 (2%) 138 (100%)
Outpatient 0 3 (38%) 4 (50%) 0 1 (13%) 0 8 (100%)
Both 0 2 (33%) 4 (67%) 0 0 0 6 (100%)
Staff 11 (85%) 1 (8%) 0 0 0 1 (8%) 13 (100%)
Not stated 2 (15%) 7 (54%) 1 (8%) 0 1 (8%) 2 (15%) 13 (100%)
Total 78 (44%) 40 (22%) 20 (11%) 12 (7%) 22 (12%) 6 (3%) 178 (100%)
Clinical setting (number of studies)
Intensive Care Unit (ICU) 37 (61%) 19 (30%) 0 0 4 (7%) 1 (2%) 61 (100%)
Adult ICU (35) (2) (0) (0) (1) (1) (39)
Pediatric ICU (1) (1) (0) (0) (0) (0) (2)
Neonatal ICU (1) (16) (0) (0) (3) (0) (20)
Hematology/Oncology 5 (10%) 4 (8%) 16 (33%) 10 (20%) 11 (22%) 3 (7%) 49 (100%)
Operating room 18 (90%) 0 0 0 1 (5%) 1 (5%) 20 (100%)
All patients requiring vascular access/outpatients/not
stated
2 (10%) 10 (50%) 4 (20%) 1 (5%) 3 (15%) 0 20 (100%)
Education/Training facility 10 (91%) 0 0 0 0 1 (9%) 11 (100%)
Medical/Surgical 2 (25%) 3 (38%) 0 1 (12%) 2 (25%) 0 8 (100%)
Combined 4 (66%) 1 (17%) 0 0 1 (17%) 0 6 (100%)
Radiology department 0 3 (100%) 0 0 0 0 3 (100%)
Emergency department* 0 0 0 0 0 0 0
Total 78 (45%) 40 (22%) 20 (11%) 12 (7%) 22 (12%) 6 (3%) 178 (100%)
*Two studies were undertaken in ED in conjunction with other clinical areas, but no study was undertaken in ED alone.
RCT: Randomized Controlled Trial; CVAD: Central Venous Access Device; NTCVAD: Non-tunneled Central Venous Access Device; PICC: Peripherally
Inserted Central Catheter; TIVAD: Totally Implantable Vascular Access Device; CVAD NS: Central Venous Access Device Not Specified
https://doi.org/10.1371/journal.pone.0174164.t001
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access teams including nurses inserted CVADs in 17 RCTs (9%), and radiologists inserted
CVADS in 13 RCTs (7%).
Interventional themes of included RCTs
Among all CVAD types, insertion technique was the most common topic (51 RCTs, 29% of all
studies), followed by lock solutions (22 RCTs, 12%) (See Fig 2, S2 and S3 Tables for detailed per
CVAD type table). Only five studies examined flushing technique, in contrast to more common
lock solution studies (22 RCTs). There were only one or two studies on each of the following
topics: bundle interventions, securement, in-line filters, administration sets, unblocking solu-
tions, and patient education.
There were 433 individual outcomes in this review, which were categorized into seven
major themes (See Table 2). The most prevalent outcomes studied were: infective (n = 161,
37%), followed by catheter complications (n = 99, 23%), and catheter insertion outcomes
(n = 101, 23%). These major categories were further subdivided into sub-categories (See S4
Table to see the variety of definitions of outcomes across the studies).
Discussion
This scoping review is the first to systematically identify the gaps in the recent RCT evidence
for CVAD use. Many studies included in the review (67 RCTs, 38%) focused on effective
CVAD insertion practices, however, comparatively few evaluated maintenance strategies, such
as infection prevention (15 RCTs, 8%) and dressing and securement (12 RCTs, 7%). Important
areas such as securement, patient education, and bundled interventions lack RCT data.
The findings of this review accord with a recent scoping review of RCTs in peripheral vas-
cular access catheters, which found catheter insertion strategies were extensively studied, but
there was a lack of robust evidence to support post-insertion care and maintenance, including
dressings and securement, flushing practices, and infection prevention strategies [203]. CVAD
insertion complications occur in 0.4–4.5% of procedures, in comparison to post-insertion
complications, which can occur in up to 25% of the device life [5, 204–206]. CVADs are
designed for prolonged use compared to peripheral intravenous catheters, and more evidence
Fig 2. Interventional themes of included RCTs (N = 178 RCTs).
https://doi.org/10.1371/journal.pone.0174164.g002
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Table 2. Study outcomes (N = 433) of included RCTs (Detailed table per CVAD type in S4 Table).
Reported Study Outcomes Totals
Catheter complications, N (%) 99 (22.9%)
Thrombosis 29 (6.7%)
Occlusion 23 (5.3%)
Mechanical failure a 15 (3.4%)
Early removal 14 (3.3%)
Dwell time 12 (2.8%)
Complication rate (not specified) 5 (1.2%)
Local edema/ inflammation 1 (0.2%)
Patient outcomes, N (%) 29 (6.6%)
Pain scores 14 (3.2%)
Patient satisfaction/ Quality of life 6 (1.4%)
Vital signs 3 (0.7%)
Mortality rate 3 (0.7%)
Psychological distress 1 (0.2%)
Patient comprehension 1 (0.2%)
Self-management ability 1 (0.2%)
Catheter insertion outcomes, N (%) 101 (23.3%)
Successful placement measures 47 (10.9%)
Insertion-related complications 39 (9.0%)
Insertion success: performance scores 13 (3.0%)
Use of ultrasound 1 (0.2%)
Requirement for repositioning 1 (0.2%)
Infective outcomes, N (%) 161 (37.2%)
Catheter-related blood stream infection 47 (10.9%)
Catheter-related infection 29 (6.7%)
CVAD tip colonization 29 (6.7%)
Contamination/ colonization of non-catheter materials including skin and hub 20 (4.6%)
Systemic infection/sepsis/ fever 18 (4.2%)
Local infection/ exit-site infection/phlebitis 17 (3.9%)
Microbial biofilm 1 (0.2%)
Patency-related outcomes, N (%) 10 (2.3)
Patency 5 (1.2%)
Thrombolytic/ fibrinolysis injection 4 (0.9%)
Anticoagulant treatment 1 (0.2%)
Intervention-related outcomes, N (%) 21 (4.8%)
Side effects/ tolerability 16 (3.7%)
Bleeding 4 (0.9%)
Skin necrosis 1 (0.2%)
Health service-related outcomes, N (%) 12 (2.8%)
Health economics/cost 12 (2.8%)
TOTAL 433 (100%)
a Mechanical failures include migration, catheter defects, malfunction, infiltration, skin fixation failure,
dislocation, fracture and other.
https://doi.org/10.1371/journal.pone.0174164.t002
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for post-insertion care is needed to avoid unnecessary complications and the need for catheter
replacement.
It is important that the same RCT questions and outcome variables are replicated in several
RCTs in different clinical settings before a precise and reliable assessment of effect can be
determined, preferably in a systematic review and meta-analysis. Our review highlighted that
this depth of RCT testing is not yet present in the literature for all areas of CVAD manage-
ment, with many single RCTs focusing on an intervention in one study only [25, 47, 58, 67, 70,
72, 91, 107, 108, 122, 156, 163, 168, 177, 181, 185, 187, 194, 195, 199]. The potential barriers to
undertaking and publishing RCTs in vascular access are likely to be due to a lack of research
knowledge, skills, and funding. However, many such issues could be resolved if vascular access
teams and other health professionals affiliate with local academics and incorporate research
and publishing within their service roles [207].
In addition, the scoping review revealed the variety of outcome definitions used, particu-
larly for infection outcomes. For example, CRBSI as per the Centers for Disease Control and
Prevention (CDC) definition; CRBSI defined by other references [208–214], catheter-related
infection defined by the authors, catheter-related infection not specified, and catheter-related
sepsis. Half of the CRBSI outcomes included within the scoping review were defined by refer-
ences other than the CDC, with some references dating from the 1990s despite the included
RCTs being published from 2006 onwards. Furthermore, many catheter-related infections
were not defined. Such heterogeneous reporting of infective outcomes makes the comparison
of studies problematic and, with the weak effect, cannot be extrapolated to clinical practice.
CVAD-associated thrombosis outcomes were also diagnosed differently across studies. In
the review thrombosis was categorized into three categories: 1. Diagnosed and screened by
instruments, such as venography, ultrasound, MRI or CT scans; 2. Diagnosed clinically and
then scanned by instruments; and 3. Diagnosed clinically only. Around 33% of the thrombosis
outcome studies did not screen patients with instruments. This could potentially lessen the
effect when compared to the studies that screened for thrombosis for all patients. With variable
definitions, it is difficult to relate the evidence to clinically important outcomes. There is a
need for consensus on definition for catheter complications including mechanical and infec-
tive outcomes in order to have meaningful results that are comparable across studies.
Pediatrics and neonates have been understudied across all CVAD types. There were only 18
RCTs in pediatrics, 20 RCTs in neonates, and 3 in combined adults and pediatrics, compared
to 119 adult RCTs. Previous systematic reviews have concluded that more evidence from this
population group is required to reach significant results in meta-analysis [215, 216]. Neonatal
and pediatric populations have different underlying anatomy and physiology and indications
for CVAD insertion and use. It is not recommended to extrapolate results from adult RCTs to
neonatal and pediatric populations, where physiological and technical reasons may modify the
effect [217]. Therefore, pediatric and neonatal clinicians have inadequate evidence on which to
base their vascular access practice, which could contribute to poorer outcomes for children,
families and the healthcare system. More RCTs to provide evidence to support CVAD inser-
tion and management decisions are urgently needed in this vulnerable population [217].
This scoping review has several limitations. Primarily, it did not examine the risk of bias as
assessed in systematic reviews. However, the aim was to capture the current CVAD themes
being studied, which this review successfully captured. Secondly, some references were ana-
lyzed from abstracts without full text available. This could have potentially misclassified some
variables due to a lack of complete information. Thirdly, research abstracts published in a lan-
guage other than English were excluded due to cost and time involved in translating material,
so these results reflect only the English literature. However, this is the first scoping review pub-
lished on RCTs on CVADs, and it has made a unique and significant contribution to the body
RCTs in CVADs: A scoping review
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of knowledge in this area. It provides a platform for prioritizing rigorous research in areas
such as CVAD maintenance to provide high level evidence to inform guidelines and practice.
Additionally, it has given future recommendations on methods and reporting of the randomi-
zation process and unification of outcome definitions for RCT findings to be significant and
useful for systematic reviews.
Conclusion
This scoping review has identified RCTs in a range of CVAD types to detect the gaps in evi-
dence and highlight areas needing further research. Many RCTs focus on insertion-related
themes, but there is a scarcity of RCTs in post-insertion care. There is also a need for consen-
sus on outcome definitions to avoid heterogeneous outcomes, such as CRBSI, catheter-related
infections, and thrombosis. Almost a quarter of RCTs did not state the randomization method,
which may degrade the quality of the study. Researchers should report their results in accor-
dance with the relevant CONSORT reporting guidelines including randomization method to
ensure reliability [218].
More RCTs in post-insertion care are necessary, and these can be encouraged by having
more interdisciplinary collaboration for CVAD research, including doctors, nurses, allied
health professionals and patients. There are over 5 million CVADs inserted every year in the
United States [219]. A recent systematic review of CVAD complications in pediatrics found
that 25% of CVADs failed before completion of therapy [5]. The estimated proportion of cath-
eter failure from all CVAD complications for adults is still unknown. In 2009, an estimated
18,000 central line-associated bloodstream infections occurred in ICU patients in the United
States, with a single episode costing up to US$22,939 [220, 221]. These potentially preventable
injuries cause direct harm to patients and place an enormous financial strain on healthcare
institutions. This study has identified that more high quality evidence is necessary to inform
CVAD maintenance practices to avoid such complications to reduce unnecessary CVAD
replacements and associated cost.
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